Samsung Life Insurance Special Account Slightly Sells Samsung Biologics Shares; No Change in Major Shareholder Stake


  • Total shares held by major shareholders (Samsung C&T, Samsung Electronics, Samsung Life Insurance Special Account, executives) are 34,396,950 shares (74.31% stake), a decrease of 1,835 shares from the previous report, but the stake percentage unchanged.
  • Samsung Life Insurance (Special Account) net sold approximately 1,835 shares through open market transactions during April 6-30, 2026, reducing its holdings to 14,206 shares.

KOSPI Filing Information


  • Report on Change in Ownership of Major Shareholders, etc.
  • Company: Samsung Biologics (207940)
  • Submission: Samsung Biologics Co., Ltd.
  • Under KRX KOSPI Market Division

  • Shares: 46,290,951
  • Price: 1,470,000 KRW
  • Market Cap: 68,047.7 B KRW